CIK 0001740279 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
IN8BIO, INC.
Sign in to watch- Ticker
- INAB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 825462585
- Phone
- (646) 600-6438
- Business address
- EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330, NEW YORK, NY, 10118
- Former names
- Incysus Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 68 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-13 | Brandt Peter C. Director | Grant or award · Series B Warrants (right to buy) | +81,967 | 81,967 | ||
| 2023-12-13 | Kreis Leslie W. 10% owner | Purchase · Pre-Funded Warrants | +574,241 | 574,241 | ||
| 2023-12-13 | Kreis Leslie W. 10% owner | Purchase · Series A Warrant | +574,241 | 574,241 | ||
| 2023-12-13 | Kreis Leslie W. 10% owner | Purchase · Series B Warrant | +574,241 | 574,241 | ||
| 2023-12-13 | Fletcher Aaron G.L. 10% owner | Purchase · Pre-Funded Warrants | +574,241 | 574,241 | ||
| 2023-12-13 | Fletcher Aaron G.L. 10% owner | Purchase · Series A Warrant | +574,241 | 574,241 | ||
| 2023-12-13 | Fletcher Aaron G.L. 10% owner | Purchase · Series B Warrant | +574,241 | 574,241 | ||
| 2023-12-06 | Epperly Corinne Director | Grant or award · Stock Option (right to buy) | +54,800 | 54,800 | ||
| 2023-09-13 | Graff Jeremy R. Director | Purchase | +2,500 | $0.95 | $2K | 2,500 |
| 2023-08-25 | McCall Patrick Chief Financial Officer | Purchase | +1,000 | $1.03 | $1K | 6,263 |
| 2023-08-24 | Ho William Tai-Wei President and CEO | Purchase | +23,800 | $1.05 | $25K | 2,339,545 |
| 2023-07-28 | FAIRBAIRN EMILY Director | Other disposition | −4,111,958 | 0 | ||
| 2023-06-21 | Goswami Trishna Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +134,000 | 134,000 | ||
| 2023-06-21 | McCall Patrick Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +87,150 | 87,150 | ||
| 2023-06-21 | Rochlin Kate Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +67,800 | 67,800 | ||
| 2023-06-21 | Lamb Lawrence EVP and CSO | Grant or award · Employee Stock Option (right to buy) | +77,600 | 77,600 | ||
| 2023-06-21 | Ho William Tai-Wei President and CEO | Grant or award · Employee Stock Option (right to buy) | +393,950 | 393,950 | ||
| 2023-06-15 | Brandt Peter C. Director | Grant or award · Stock Option (right to buy) | +85,000 | 85,000 | ||
| 2023-04-14 | Ho William Tai-Wei President and CEO | Grant or award · Employee Stock Option (right to buy) | +393,950 | 393,950 |
Page 9 of 9 · 179 trades